Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • iPad

    - PMLiVE

    UK drug repurposing study identifies several potential dementia treatments

    An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

    - PMLiVE

    AI tool better predicts progress of Alzheimer’s versus current clinical tests

    The most common form of dementia accounts for up to 80% of all cases

    - PMLiVE

    Study identifies thousands of high-risk cancer gene variants and potential therapeutic target

    Patients with inherited variants of the BAP1 gene have a 50% increased risk of developing certain cancers

    - PMLiVE

    Researchers’ new vaccine technology shows efficacy against broad range of coronaviruses

    The vaccine provided protection against coronaviruses that have not yet emerged

    - PMLiVE

    New immune cell discovery could lead to personalised breast cancer treatments

    The study revealed the key features of immune cells in helping the body’s immune system fight cancer

    - PMLiVE

    UK study reveals significantly higher risk of second cancers among breast cancer survivors

    Breast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually

    - PMLiVE

    Single genetic test could replace current standard for diagnosing rare developmental disorders

    The single genetic test could potentially replace the current standard and reduce costs for the NHS

    - PMLiVE

    Study reveals molecular signatures driving immune cell attacks in chronic neurological diseases

    MS is a chronic neurological disease that affects more than two million people worldwide

    - PMLiVE

    Cambridge study reveals potential biomarker and target for long COVID treatments

    The pro-inflammatory molecule, IFN-Y, persisted until symptoms improved in patients

    - PMLiVE

    Researchers uncover role of inherited genetic variants in rare blood cancer

    There are around 4,000 cases of myeloproliferative neoplasms in the UK each year

    - PMLiVE

    Stem cell therapy trial shows promising results for treating progressive MS

    The early-stage trial shows the potential to develop an advanced cell therapy treatment

    - PMLiVE

    Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients

    About one-third of adults living with diabetes die from a heart or circulatory disease

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links